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Objectives. The inverse and independent association between cardiorespiratory fitness (CRF) and arterial 
thrombotic disease is well established. However, the potential association between CRF and venous 
thromboembolism (VTE) is not well known. We aimed to assess the prospective association of CRF with 
the risk of VTE. Design. Cardiorespiratory fitness, as measured by maximal oxygen uptake (VO2max), was 
assessed using a respiratory gas exchange analyser in 2,249 men aged 42-61 years without a history of 
VTE at baseline in the Kuopio Ischemic Heart Disease prospective cohort. Cox-regression models were 
used to calculate hazard ratios (HR) with 95% confidence interval (CI) for VTE. We corrected for within-
person variability in CRF levels using data from repeat measurements taken several years apart. Results. 
There were 144 (6.4%) incident VTE events recorded during a median follow-up of 25.2 years. The age-
adjusted regression dilution ratio of CRF was 0.58 (95% CI: 0.53 to 0.64). The risk of VTE did not 
decrease per 1 standard deviation increase in CRF in age-adjusted analysis (HR 0.90; 95% CI 0.75–1.08). 
The association remained consistent on analyses adjusted for several established and emerging risk 
factors (HR 0.90; 95% CI 0.73–1.12). The corresponding adjusted HRs were 0.80 (95% CI: 0.52-1.23) 
and 0.82 (95% CI: 0.51-1.32) respectively, when comparing the extreme tertiles of CRF levels. 
Conclusions. In a middle-aged Caucasian male population, CRF was not associated with future risk of 










Venous thromboembolism (VTE) (comprising deep  vein thrombosis (DVT) and pulmonary embolism 
(PE)), which is associated with substantial morbidity, high economic costs and premature mortality [1,2], 
constitutes a substantial public health burden and is a preventable health condition.  Venous 
thromboembolism is closely linked to atherosclerotic cardiovascular disease (CVD) and evidence 
suggests both conditions share some common risk factors [3,4]. Though both disease states have 
historically been viewed as two distinct diseases [5], they share common characteristics such as 
coagulation and platelet activation, hence they may have common pathophysiological mechanisms [6]. 
The inverse and independent relationship between regular physical activity and arterial thrombotic disease 
is well established [7-9]. Till recently, evidence on the association between physical activity and the risk 
of VTE was divergent. In a pooled meta-analysis of 14 prospective cohort studies, we have shown that 
regular physical activity is associated with reduced risk of VTE [10]. Cardiorespiratory fitness (CRF), as 
measured by maximal oxygen uptake (VO2max), is the gold standard for assessing aerobic capacity and is 
an index of habitual physical activity [11]. Like physical activity, CRF has also been consistently shown 
to be independently and inversely associated with vascular outcomes [12]. Given the overall evidence, we 
postulated that CRF may be linked to the risk of VTE. In this context, we aimed to assess the prospective 
association of CRF with risk of VTE, using a population-based prospective cohort of 2249 middle-aged 
Caucasian men.  
 
Methods 
The current analysis is based on the Kuopio Ischemic Heart Disease (KIHD) risk factor study, a general 
population-based prospective cohort study comprising of middle-aged men aged 42-61 years who were 
recruited from Kuopio in eastern Finland. Study design, recruitment methods and assessment of risk 
markers have been described previously [13]. The actual baseline cohort consisted of 2,682 participants 




analysis, complete information on CRF, relevant covariates, and VTE outcomes was available for 2,249 
men. Written informed consent was obtained from all participants and the research protocol was approved 
by the institutional review board of the University of Eastern Finland and all study procedures were 
conducted according to the Declaration of Helsinki. Maximal oxygen uptake (VO2max) was used as a 
measure of CRF and was estimated using a respiratory gas exchange analyzer during cycle ergometer 
exercise tests. A detailed description of the measurement of VO2max has been reported previously [14]. As 
a result of measurement errors in exposure estimation, lifestyle changes, and aging in prospective cohort 
studies, analysis using only baseline measurements of an exposure could underestimate the true strength 
of any association between exposure and outcome (i.e. “regression dilution bias”[15]). To clarify this 
issue, using repeat measurements of repeat measurements of VO2max 11 years apart in a random subset of 
565 men, we estimated and corrected for the effect of this regression dilution bias. We included all first 
lifetime VTE events that occurred from study enrollment through to 2017. These were identified by 
computer linkage to the National Hospital Discharge Registry data and a comprehensive review of 
available hospital records. The diagnosis of DVT or PE required positive imaging tests. Hazard ratios 
(HRs) with 95% confidence intervals (CIs) were calculated using Cox proportional hazard models after 
confirming the assumptions of proportionality of hazards.[16] We selected covariates based on their 
potential as confounders as a result of their known associations with VTE outcomes and observed 
associations with CRF using the available data[17] and evidence from previous research.[13]All statistical 
analyses were conducted using Stata version 15 (Stata Corp, College Station, Texas). 
 
Results 
The baseline characteristics of study participants are presented in Table 1. The mean [standard deviation 
(SD)] age, BMI, and CRF of 2,249 study subjects at baseline were 53 (5) years, 26.9 (3.5) kg, and 30.2 
(8.0) mL/(kg.min) respectively. During a median (interquartile range) follow-up of 25.2 (18.0-27.1) years, 




recorded. The HR for VTE per 1 SD increase in CRF in analysis adjusted for age was 0.90 (95% CI: 0.75 
to 1.08), which remained consistent in analyses adjusted for established risk factors (systolic blood 
pressure, prevalent coronary heart disease, smoking status, history of diabetes, total cholesterol, 
triglycerides, lipid medication, total physical activity, alcohol consumption, prevalent cancer, and high 
sensitivity C-reactive protein) 0.90 (95% CI: 0.73 to 1.12) (Table 2). The corresponding adjusted HRs 
were 0.80 (95% CI: 0.52 to 1.23) and 0.82 (95% CI: 0.51 to 1.32) respectively, when comparing the 
extreme tertiles of CRF levels. The overall age-adjusted regression dilution ratio of CRF was 0.58 (95% 
CI: 0.53 to 0.64), which suggests that if there was a significant association between CRF and VTE, using 
one-off or baseline measurements of CRF could under-estimate the risk by [(1/0.58)-1]*100 = 72%. The 
HRs were more extreme after correction for within-person variability in CRF levels (Table).  
 
Discussion 
Previous observational cohort data supports an inverse association between CRF and arterial thrombotic 
disease [12]. To the best of our knowledge, this is the first study to examine the prospective association 
between objectively measured CRF and risk of VTE in a general population-based cohort of middle-aged 
Caucasian men. Our results demonstrate no evidence of an association between CRF and future risk of 
VTE, either in analysis using CRF as a continuous or categorical variable. 
Given the close link between atherosclerotic CVD and VTE [6],  the established relationship between 
CRF and atherosclerotic CVD,[12] CRF being an objective index of habitual physical activity, and the 
fact that both disease entities conditions share physical inactivity as a common risk factor [10], these 
findings may seem unexpected. Though regular physical activity leads to improved CRF, genetic as well 
as several other environmental factors influence CRF levels.  Evidence suggests that approximately half 
of the variation in CRF is attributed to heritable factors, with the contribution of inherited factors to the 
response of CRF to physical activity approximating 45-50% [18]. The level of CRF also depends on 




activity.[18]  Hence the null association observed between CRF and VTE may reflect important 
pathophysiologic differences between CRF and physical activity in the pathogenesis of VTE. There is 
also a possibility that the null findings may not be due to a true association but could be related to factors 
such as (i) age, sex, or genetic background of the population; (ii) long follow-up duration; (iii) low 
statistical power due to low VTE event rates, as VTE is not necessarily a common outcome in middle-
aged men; and (iv) VTE occurrence due to factors such as cancer and fractures, which are not related to 
CRF levels. Due to the absence of previous studies conducted on the topic, larger-scale studies are 
warranted to confirm or refute these findings. More specifically, other age-groups and women should be 
targeted in the future.  
Several strengths of this study deserve mention and these include novelty, the large sample size, the 
prospective cohort design, the representativeness of the sample in the general population, the long-term 
follow-up and repeat measurements of directly assessed CRF allowing for quantification of regression 
dilution. Limitations included the inability to generalise the results to women and other populations, data 
was available on only total VTEs which precluded the ability to evaluate specific VTE outcomes (DVT or 
PE), and the relatively low VTE event rate. 
 
Conclusions 
In a middle-aged Caucasian male population, CRF was not associated with future risk of VTE, suggesting 
that CRF may not play an important role in the pathogenesis of VTE. Furthermore, there may be 
important pathophysiologic differences between physical activity and CRF in the pathogenesis of VTE. 
The relationship between CRF and VTE warrants further investigation. 
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Mean (SD) or median 
(IQR) or n (%) 
 
Tertile 1 (N=750) 
Mean (SD) or median 
(IQR) or n (%) 
 
Tertile 2 (N=750) 
Mean (SD) or median 
(IQR) or n (%) 
 
Tertile 3 (N=749) 
Mean (SD) or median 
(IQR) or n (%) 
CRF (mL/(kg.min)) 30.2 (8.0) 21.7 (4.0) 30.0 (1.8) 39.0 (5.0) 
     
Questionnaire/Prevalent conditions     
Age at survey (years) 52.9 (5.1) 55.0 (4.1) 52.9 (4.8) 50.7 (5.4) 
Alcohol consumption (g/week) 32 (6-92) 32 (6-94) 34 (6-100) 30 (7-83) 
History of diabetes 79 (3.5) 48 (6.4) 21 (2.8) 10 (1.3) 
Current smokers 699 (31.1) 280 (37.3) 234 (31.2) 185 (24.7) 
History of CHD 534 (23.7) 322 (42.9) 137 (18.3) 75 (10.0) 
History of cancer 35 (1.6) 11 (1.5) 10 (1.3) 14 (1.9) 
Lipid medication 13 (0.6) 10 (1.3) 2 (0.3) 1 (0.1) 
     
Physical measurements     
BMI (kg/m2) 26.9 (3.5) 28.3 (3.8) 26.9 (3.2) 25.5 (2.7) 
SBP (mmHg) 134 (17) 136 (19) 135 (17) 131 (14) 
DBP (mmHg) 89 (10) 90 (11) 90 (11) 87 (9) 
Total physical activity (kcal/day) 287 (150-473) 259 (128-428) 282 (148-462) 321 (181-510) 
     
Lipid markers     
Total cholesterol (mmol/l) 5.91 (1.07) 6.00 (1.09) 5.94 (1.07) 5.79 (1.05) 
HDL-C (mmol/l) 1.29 (0.30) 1.22 (0.28) 1.28 (0.30) 1.38 (0.31) 
Triglycerides (mmol/l) 1.09 (0.79-1.54) 1.27 (0.92-1.78) 1.10 (0.82-1.55) 0.92 (0.69-1.29) 
     
Metabolic and inflammatory 
markers 
    
Fasting plasma glucose (mmol/l) 5.33 (1.20) 5.60 (1.58) 5.30 (0.99) 5.10 (0.86) 
Fibrinogen (g/l) 2.96 (2.62-3.32) 3.15 (2.79-3.54) 2.96 (2.63-3.29) 2.81 (2.51-3.14) 
High sensitivity CRP (mg/l) 1.24 (0.69-2.36) 1.72 (0.92-3.68) 1.31 (0.77-2.29) 0.84 (0.51-1.57) 
 
 BMI, body mass index; CHD, coronary heart disease; CRP, C-reactive protein; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein 





Table 2. Association between cardiorespiratory fitness and risk of venous thromboembolism 
 
CRF (mL/(kg.min)) Events/ 
Total 
Model 1  Model 2  
  HR (95% CI) P-value HR (95% CI) P-value 
Baseline CRF 
Per 1 SD increase 144 / 2,249 0.90 (0.75 to 1.08) 0.26 0.90 (0.73 to 1.12) 0.34 
T1 (6.36-26.86) 47 / 750 ref  ref  
T2 (26.87-33.24) 52 / 750 0.96 (0.65 to 1.44) 0.85 0.99 (0.65 to 1.49) 0.95 
T3 (33.25-65.40) 45 / 749 0.80 (0.52 to 1.23) 0.31 0.82 (0.51 to 1.32) 0.43 
Usual CRF* 
Per 1 SD increase 144 / 2,249 0.84 (0.61 to 1.15) 0.26 0.84 (0.58 to 1.21) 0.34 
T1 (6.36-26.86) 47 / 750 ref  ref  
T2 (26.87-33.24) 52 / 750 0.94 (0.47 to 1.86) 0.85 0.98 (0.48 to 2.00) 0.95 
T3 (33.25-65.40) 45 / 749 0.68 (0.32 to 1.43) 0.31 0.72 (0.32 to 1.62) 0.43 
 
CI, confidence interval; CRF, cardiorespiratory fitness; HR, hazard ratio; ref, reference; SD, standard deviation; T, tertile 
*, indicates correction for within-person variability in values of CRF, that is, the extent to which an individual’s CRF 
measurements vary around a long-term average value (“usual CRF values”) 
Model 1: Adjusted for age  
Model 2: Model 1 plus systolic blood pressure, prevalent coronary heart disease, smoking status, history of diabetes, total 
cholesterol, triglycerides, lipid medication, total physical activity, alcohol consumption, prevalent cancer, and high sensitivity C-
reactive protein 
 
 
 
 
 
 
 
 
 
 
 
